we're invested in companies that make healthcare more affordable, such as drugstore and pharmacy benefits manager (PBM) CVS Health. Perrigo fits into the second category, as its low-priced OTC and generic prescription drugs provide consumers with
CHICAGO, Nov 4 (Reuters) - CVS Health Corp reported slightly higher-than-expected quarterly results on Tuesday, helped by growth in sales of specialty drugs and new client additions in its pharmacy benefits business.
CVS reported somewhat of a mixed bag for its 2014 third-quarter results. However, the firm’s performance largely fell in line
from The Art of Successful Investing Conference: Scott Black: SWKS, SNX, AXAS Ross Margolies: DAL, RJET William Priest: CVS , SAF.fr Oscar Schafer: ANIP, BERY Meryl Witmer: NVGS, GPK Marc Faber: IOI.ma, WIL.si Pg 41: Tom Schindler runs
competitive position has improved, aggressive pricing by competitors could still hurt profitability. For example, CVS Caremark may have an incentive to underprice its PBM offering to drive more traffic to its retail stores. While some health
will watch closely how these investments develop over the course of fiscal 2015. Cardinal's generic sourcing partnership with CVS provides a positive trend. This partnership remains on track and should be accretive to fiscal 2015 earnings. We believe this
LAGUNA BEACH Calif. (Reuters) - Apple Inc CEO Tim Cook fired back at CVS and Rite Aid on Monday after the drugstore chains blocked the iPhone maker's mobile payments service, saying there were plenty of other retailers around the world to sign up.
LAGUNA BEACH, Calif., Oct 27 (Reuters) - Apple Inc CEO Tim Cook fired back at CVS and Rite Aid on Monday after the drugstore chains blocked the iPhone maker's mobile payments service, saying there were plenty of other retailers around the world to sign up.
Oct 27 (Reuters) - Drug retailers CVS Health Corp and Rite Aid Corp have disabled Apple Inc's new electronic payments service Apple Pay from their stores over the weekend, the New York Times reported.
traction and new contracts begin with Express Scripts (top drug Advair will be removed from the "exclude" list in 2015) and Caremark (competing drug Symbicort will be added to the "exclude" list). While we are concerned about the poor initial sales of